RegCell is developing cell therapies for autoimmune disease by epigenetically reprogramming pathogenic conventional T cells into stable regulatory T cells, aiming to restore immune tolerance without gene engineering; its platform is advancing toward clinical development.
LT
LG Technology Ventures
Activity from announced rounds
Activity in this selectiondeel-e58c154a
LG Technology Ventures is the corporate venture organization identified in its own Spectro Cloud release and RegCell’s investor announcement.
Recorded funding activity
Spectro manages cloud infrastructure. RegCell reprograms immune cells for cell therapies, while Zenity secures enterprise agents. The venture organization retains its identity separately from the LG parent and other named units.
- Rounds participated in
- 5
- Confirmed lead rounds
- 0 4 roles undisclosed
- New companies
- 5 First participation on record · 0 follow-on
- Funding in participating rounds
- $674M 5 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
5 in this selectionRegCell, Inc.
$44MSeries A
ParticipantZenity
AI security and governance platform purpose-built for enterprise AI agents
$125MSeries C
Role not disclosedSpectro Cloud
Helps platform teams and cloud providers modernize and manage infrastructure for the AI era
$100MSeries D
Role not disclosedCloaked
Cloaked provides privacy software for individuals.
$375MSeries B
Role not disclosedFiddler AI
Provides AI observability and security platform for enterprises
$30MSeries C
Role not disclosed